FI54120B - FRUIT PROCESSING OF PHARMACEUTICAL PRODUCTS ANTIDEPRESSIVE NETWORK OF TETRAHYDROPYRIMIDO (1,2-A) INDOL-TETRAHYDRO-1,3-DIAZEPINO (1,2-A) INDOL-OCH DIHYDROIMIDASO - Google Patents

FRUIT PROCESSING OF PHARMACEUTICAL PRODUCTS ANTIDEPRESSIVE NETWORK OF TETRAHYDROPYRIMIDO (1,2-A) INDOL-TETRAHYDRO-1,3-DIAZEPINO (1,2-A) INDOL-OCH DIHYDROIMIDASO

Info

Publication number
FI54120B
FI54120B FI45/72A FI4572A FI54120B FI 54120 B FI54120 B FI 54120B FI 45/72 A FI45/72 A FI 45/72A FI 4572 A FI4572 A FI 4572A FI 54120 B FI54120 B FI 54120B
Authority
FI
Finland
Prior art keywords
indol
dihydroimidaso
tetrahydropyrimido
diazepino
antidepressive
Prior art date
Application number
FI45/72A
Other languages
Finnish (fi)
Other versions
FI54120C (en
Inventor
Alan Chapman White
Robin Michael Black
Original Assignee
Wyeth John & Brother Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth John & Brother Ltd filed Critical Wyeth John & Brother Ltd
Application granted granted Critical
Publication of FI54120B publication Critical patent/FI54120B/en
Publication of FI54120C publication Critical patent/FI54120C/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/06Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, ***e
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32Oxygen atoms
    • C07D209/38Oxygen atoms in positions 2 and 3, e.g. isatin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/20Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/20Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D233/22Radicals substituted by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Diabetes (AREA)
  • Psychiatry (AREA)
  • Cardiology (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Nutrition Science (AREA)
  • Endocrinology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Indole Compounds (AREA)
FI45/72A 1971-01-11 1972-01-10 FRUIT PROTECTION FOR PHARMACEUTICAL FRAMEWORK ANVAIDBARA ANTIDEPRESSIVT VERKANDE TETRAHYDROPYRIMIDO (1,2-A) INDOL-TETRAHYDRO-1,3-DIAZEPINO (1-2-A) INDOL-OCH DIHYDROIMIDASO FI54120C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB125071*[A GB1366133A (en) 1971-01-11 1971-01-11 Fused ring indole derivatives
GB4095971 1971-09-02
GB5646771 1971-12-06

Publications (2)

Publication Number Publication Date
FI54120B true FI54120B (en) 1978-06-30
FI54120C FI54120C (en) 1978-10-10

Family

ID=27253859

Family Applications (1)

Application Number Title Priority Date Filing Date
FI45/72A FI54120C (en) 1971-01-11 1972-01-10 FRUIT PROTECTION FOR PHARMACEUTICAL FRAMEWORK ANVAIDBARA ANTIDEPRESSIVT VERKANDE TETRAHYDROPYRIMIDO (1,2-A) INDOL-TETRAHYDRO-1,3-DIAZEPINO (1-2-A) INDOL-OCH DIHYDROIMIDASO

Country Status (20)

Country Link
JP (1) JPS5531156B2 (en)
AR (1) AR192734A1 (en)
AT (1) AT312595B (en)
AU (1) AU464388B2 (en)
BE (1) BE777911A (en)
CA (1) CA1012150A (en)
CH (1) CH573938A5 (en)
CY (1) CY926A (en)
DK (1) DK150143C (en)
EG (1) EG10888A (en)
ES (2) ES398678A1 (en)
FI (1) FI54120C (en)
FR (1) FR2121699B1 (en)
GB (1) GB1366133A (en)
HK (1) HK52877A (en)
IE (1) IE35956B1 (en)
KE (1) KE2777A (en)
MY (1) MY7800048A (en)
NL (1) NL174251C (en)
SE (1) SE398645B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1520611A (en) * 1976-06-11 1978-08-09 Wyeth John & Brother Ltd Fused ring indole derivatives
JPS5845741B2 (en) * 1977-06-06 1983-10-12 株式会社日立製作所 information retrieval device
ZA824382B (en) * 1981-07-07 1984-02-29 Wyeth John & Brother Ltd Anti-obesity agents
JPS60204057A (en) * 1984-03-28 1985-10-15 Casio Comput Co Ltd Small-sized electronic apparatus with data storage function
GB8606253D0 (en) * 1986-03-13 1986-04-16 Wyeth John & Brother Ltd Pyrimidoindoles
GB8606254D0 (en) * 1986-03-13 1986-04-16 Wyeth John & Brother Ltd Substituted pyrimidoindoles
GB8614246D0 (en) * 1986-06-11 1986-07-16 Wyeth John & Brother Ltd Substituted pyrimidoindoles
WO2010090680A1 (en) * 2008-12-15 2010-08-12 Wyeth Llc Substituted oxindole cb2 agonists

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3888846A (en) * 1967-03-30 1975-06-10 Hoffmann La Roche Process for 2(2-(1,3-diazacycloalk-2-enyl))benzophenone derivatives and 1,3-diazacycloalkenyl(2,1-a)isoindole derivatives
US3586693A (en) * 1969-07-07 1971-06-22 American Home Prod Imidazo(1,2-a)indolin-9-ols

Also Published As

Publication number Publication date
GB1366133A (en) 1974-09-11
NL7200415A (en) 1972-07-13
AU3755872A (en) 1973-07-05
JPS5531156B2 (en) 1980-08-15
DK150143C (en) 1987-06-01
BE777911A (en) 1972-07-11
MY7800048A (en) 1978-12-31
HK52877A (en) 1977-10-20
AR192734A1 (en) 1973-03-14
CY926A (en) 1977-12-23
KE2777A (en) 1977-10-21
IE35956B1 (en) 1976-07-07
NL174251C (en) 1984-05-16
FI54120C (en) 1978-10-10
SE398645B (en) 1978-01-09
JPS4839500A (en) 1973-06-09
NL174251B (en) 1983-12-16
FR2121699B1 (en) 1975-08-01
EG10888A (en) 1978-06-30
CA1012150A (en) 1977-06-14
CH573938A5 (en) 1976-03-31
DK150143B (en) 1986-12-15
IE35956L (en) 1972-07-11
AU464388B2 (en) 1975-08-28
AT312595B (en) 1974-01-10
FR2121699A1 (en) 1972-08-25
ES409296A1 (en) 1976-03-16
ES398678A1 (en) 1975-05-16

Similar Documents

Publication Publication Date Title
SE399427B (en) PROCEDURE FOR THE PREPARATION OF 2,4 DIAMINO-BENZYLPYRIMIDINES
FI48593C (en) Process for the preparation of blood glucose lowering bornylene and nor-bornylene / 2,3-d / -N- (p-tolylsulfonylcarboxamino) -oxazolidinones.
FI54120B (en) FRUIT PROCESSING OF PHARMACEUTICAL PRODUCTS ANTIDEPRESSIVE NETWORK OF TETRAHYDROPYRIMIDO (1,2-A) INDOL-TETRAHYDRO-1,3-DIAZEPINO (1,2-A) INDOL-OCH DIHYDROIMIDASO
CH522365A (en) Food preparation process
FI54310C (en) FRUIT PROCEDURE FOR FRAMSTAELLNING AV NYA SAOSOM LAEKEMEDEL ANVAENDBARA 6-PHENYL-4H-S-TRIAZOLO (1,5-A) (1,4) BENZODIAZEPINE-2-CARBOXAMIDER
AR192347A1 (en) PROCEDURE FOR THE PREPARATION OF 3-AMINO-IMIDAZO (1,5-A) PYRIDINES
CH551431A (en) PREPARATION OF PYRROLO (3,4-B) DERIVATIVES PYRIDINE.
FI55660C (en) FRUIT PROTECTION FOR THERAPEUTIC USE OF THERAPEUTIC PYRAZOLO (3,4-B) PYRIDINDERIVAT
IL40043A0 (en) Benzodiazepine derivatives,their preparation and pharmaceutical compositions containing them
CA940134A (en) Imidazo (1,2-a) benzimidazole derivatives and process for the preparation thereof
SE380804B (en) ANOLOGY PROCEDURE FOR THE PREPARATION OF S-TRIAZOLO (1,5-A) (1,4)
IL40886A (en) 3(4)-alkanoyl-imidazo-(or pyrimido)benzodiazepine derivatives,their preparation and pharmaceutical compositions containing them
SE399709B (en) METHOD OF PREPARING PYRIMIDO (1,2-A) (1,4) BENSODIAZEPINES
SE7602150L (en) INTERMEDIATE PRODUCTS FOR THE PREPARATION OF 4A-ARYL-TRANS-DEKAHYDROISOKINOLINE
SE382983B (en) ANALOGICAL PROCEDURE FOR THE PREPARATION OF OXAZOLO (3,2-D) (1,4) BENZODIAZEPINE DERIVATIVES
FI55664C (en) PROCEDURE FOR FRAMSTRATION OF BLODTRYCKSSAENKANDE 5-OXO-2,3-DIHYDRO-IMIDAZO- (1,2-A) -S-TRIAZINER
NL149082B (en) PROCESS FOR PREPARING PHARMACEUTICAL PREPARATIONS, FORMED PREPARATIONS AND PROCESS FOR PREPARING SUITABLE THIAZOLINO (3,2-A) -5-PYRIMIDIN DERIVATIVES.
SE7806349L (en) INTERMEDIATE PRODUCTS INTENDED FOR THE PREPARATION OF TRIEN-STEROID DERIVATIVES
NL147141B (en) PROCESS FOR THE PREPARATION OF MEDICINAL BENZODIAZEPINE DERIVATIVES, PROCESS FOR THE PREPARATION OF A MEDICINAL PRODUCT WITH ANTIBACTERIAL RESPECTIVE ANTIVIRAL ACTION AND AN OBJECT SO OBTAINED.
SE405249B (en) PROCEDURE FOR PREPARING IMIDAZO (2,1-A) ISOINDOLES
FI52092C (en) Process for the preparation of 2-alkyl-6-phenyl-2,4-dihydro-1H-s-triazolo (4,3-a) (1,4) benzodiazepin-1-one-5N-oxide derivatives useful as medicaments.
IL34993A (en) 7alpha-methyl-13beta-alkyl-17beta-hydroxygona-4,11-dien-3-one and derivatives and process of preparation
ZA703538B (en) Treatment of agricultural products
AU430505B2 (en) Preparation of tetrafluoroethylene oligomers
AU1204870A (en) Preparation of tetrafluoroethylene oligomers